Alicia Collins Bristol Myers Squibb

Alicia Collins is the head of Cell Therapy Global Supply Planning & Management at Bristol Myers Squibb, and part of the team that commercially launched the company’s first two cell therapy products. Alicia is accountable for capacity planning, materials planning & procurement, and management of the global sales, development, & operations planning process. Alicia has 24 years of experience in the pharmaceutical and biotech industry at Merck, Genentech, and BMS in both domestic and international roles. Her experience encompasses supply chain, manufacturing, contract manufacturing, and materials management. Alicia has a B.S. in Integrated Science & Technology with a double-concentration in biotechnology and environmental science from James Madison University.